Literature DB >> 15160403

Confidence intervals for the effect of a prognostic factor after selection of an 'optimal' cutpoint.

Norbert Holländer1, Willi Sauerbrei, Martin Schumacher.   

Abstract

When investigating the effects of potential prognostic or risk factors that have been measured on a quantitative scale, values of these factors are often categorized into two groups. Sometimes an 'optimal' cutpoint is chosen that gives the best separation in terms of a two-sample test statistic. It is well known that this approach leads to a serious inflation of the type I error and to an overestimation of the effect of the prognostic or risk factor in absolute terms. In this paper, we illustrate that the resulting confidence intervals are similarly affected. We show that the application of a shrinkage procedure to correct for bias, together with bootstrap resampling for estimating the variance, yields confidence intervals for the effect of a potential prognostic or risk factor with the desired coverage. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15160403     DOI: 10.1002/sim.1611

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  25 in total

1.  Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  BMC Med       Date:  2012-05-29       Impact factor: 8.775

2.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  PLoS Med       Date:  2012-05-29       Impact factor: 11.069

3.  Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.

Authors:  Benjamin Houdu; Charline Lasnon; Idlir Licaj; Guy Thomas; Pascal Do; Anne-Valerie Guizard; Cédric Desmonts; Nicolas Aide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-14       Impact factor: 9.236

4.  Predictors of pain and disability outcomes in one thousand, one hundred and eight patients who underwent lumbar discectomy surgery.

Authors:  Chad E Cook; Paul M Arnold; Peter G Passias; Anthony K Frempong-Boadu; Kristen Radcliff; Robert Isaacs
Journal:  Int Orthop       Date:  2015-04-01       Impact factor: 3.075

5.  Links between breast cancer and birth weight: an empirical test of the hypothesized association between size at birth and premenopausal adult progesterone concentrations.

Authors:  Krista M Milich; Caroline Deimel; Franka S Schaebs; Jonathan Thornburg; Tobias Deschner; Virginia J Vitzthum
Journal:  Horm Cancer       Date:  2015-04-17       Impact factor: 3.869

6.  Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States.

Authors:  A Lindsay Frazier; Juliet P Hale; Carlos Rodriguez-Galindo; Ha Dang; Thomas Olson; Matthew J Murray; James F Amatruda; Claire Thornton; G Suren Arul; Deborah Billmire; Furqan Shaikh; Farzana Pashankar; Sara Stoneham; Mark Krailo; James C Nicholson
Journal:  J Clin Oncol       Date:  2014-12-01       Impact factor: 44.544

7.  Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD.

Authors:  M Zeisbrich; N Becker; A Benner; A Radujkovic; K Schmitt; J Beimler; A D Ho; M Zeier; P Dreger; T Luft
Journal:  Bone Marrow Transplant       Date:  2017-06-26       Impact factor: 5.483

8.  Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis.

Authors:  Mark W Ball; Michael A Gorin; Sam B Bhayani; Craig G Rogers; Michael D Stifelman; Jihad H Kaouk; Homayoun Zargar; Susan Marshall; Jeffrey A Larson; Haider M Rahbar; Bruce J Trock; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Urol Oncol       Date:  2014-12-11       Impact factor: 3.498

9.  Data integration and exploration for the identification of molecular mechanisms in tumor-immune cells interaction.

Authors:  Bernhard Mlecnik; Fatima Sanchez-Cabo; Pornpimol Charoentong; Gabriela Bindea; Franck Pagès; Anne Berger; Jerome Galon; Zlatko Trajanoski
Journal:  BMC Genomics       Date:  2010-02-10       Impact factor: 3.969

10.  Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases.

Authors:  Anna S Berghoff; Elisabeth Fuchs; Gerda Ricken; Bernhard Mlecnik; Gabriela Bindea; Thomas Spanberger; Monika Hackl; Georg Widhalm; Karin Dieckmann; Daniela Prayer; Amelie Bilocq; Harald Heinzl; Christoph Zielinski; Rupert Bartsch; Peter Birner; Jerome Galon; Matthias Preusser
Journal:  Oncoimmunology       Date:  2015-06-09       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.